Curie.Bio

Curie.Bio is at the forefront of biotechnology research, dedicated to fostering innovation and developing crucial new medicines. As a venture capital firm, Curie.Bio invests directly in promising existing companies, facilitates the creation of focused spinouts, and supports entrepreneurs in building companies from the ground up.

With a substantial $1 billion under management for seed and Series A rounds, Curie.Bio leverages a team of 100 experts whose collective knowledge has contributed to the development of over 40 FDA-approved drugs. This extensive experience allows Curie.Bio to work closely with founders, ensuring the efficient achievement of critical milestones.

Operating from its primary location in Remote, US, Curie.Bio is committed to advancing therapeutics and venture capital within the biotechnology sector. Curie.Bio is poised to continue its significant impact on drug discovery and development. We invite the management team at Curie.Bio to create a customized and exclusive company showcase and product listing on our platform to further amplify your reach and success.